ArticleMethods in molecular biology (Clifton, N.J.)2026
Selecting Novel Retino-tropic AAV Capsids by Directed Evolution.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The selection of novel AAV variants for retinal transduction has been successful for several model systems in the past. Despite this, the publication of a full directed evolution protocol that explains all steps from basic library generation techniques to the selection of suitable candidates for further testing is lacking. The following methods chapter provides a detailed protocol for the generation of an AAV library and the recovery of the most functional candidates using highly predictive transgene expression-driven selection platform. It is important to note that multiple selection platforms have been developed to date, each with unique set of strengths and weaknesses. However, the choice of a selection platform most suitable for given AAV bioengineering application is beyond the scope of this chapter. For the purpose of this chapter, we will describe steps involved in generation of an exemplar peptide insertion library into the variable region VIII of the AAV2 capsid, but the steps outlined can be extended to all other serotypes and other surface loops. Furthermore, the technologies described work independently of the model system and do not require any major specialist equipment.
Indexed as
Identifiers
42020898What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.